Download Samedan’s business magazines to your device today!
Samedan Pharmaceutical Publishers produces a range of specialist titles for decision-makers across the pharmaceutical market, from R&D to drug delivery. Our 5 magazines – European Pharmaceutical Contractor, International Clinical Trials, European Biopharmaceutical Review, Pharmaceutical Manufacturing and Packing Sourcer, and Innovations in Pharmaceutical Technology – are all leaders in their respective sectors, while our monthly newspaper, Pharmafocus, brings you breaking stories and assesses their industry impact.
Featuring in-depth news, expert articles and case studies, our publications provide timely, topical debate and discussion for pharma professionals worldwide.
This app allows you to access the latest editions for free, as well as browse our rich archive all the way back to 2008; all of which are fully searchable. Share articles with colleagues via Twitter, Facebook and email. You can also download the editions to allow for offline reading when you’re on the go.
Our app – at a glance:
•Read all our 6 titles in one place
•Access archives dating back to 2008
•Download, search within, or share the edition
•Read the edition in either portrait (single page) or in landscape (double page) view
•Tap articles on the Contents page to go straight to that feature
•Click on the page number for quick navigation
•Double tap or pinch to zoom in/out
•Return to the home page to see another title by clicking the Back button
Subscription for Samedan is free and does not expire.
For further information, help or support, please visit www.samedanltd.com/page/26
Privacy, Security, and Deception
This app collects login data in the form of email address to enable users to access content and restore previous subscriptions and purchases.
This data is only used for the access to the publication within the application and is not shown or shared with the app developers or publisher.
Data collected: Email Address.
Data use: To validate subscription and restore purchases.
This data will not be passed onto any third-parties and will not be used for any other purpose.